首页> 外国专利> still for framstellning of 7 (alpha - amino - p - hydroxifenylacetamido) - 3 - (1 - methyl - 5 - tetrazolyltiometyl) - 3 - cefem acid and 7 (alpha - amino - p - hydroxifenylacetamido) - 3 - (5 - methyl - 1,3,4 - tiadiazol - 2 - yltiometyl) - 3 - cefem...

still for framstellning of 7 (alpha - amino - p - hydroxifenylacetamido) - 3 - (1 - methyl - 5 - tetrazolyltiometyl) - 3 - cefem acid and 7 (alpha - amino - p - hydroxifenylacetamido) - 3 - (5 - methyl - 1,3,4 - tiadiazol - 2 - yltiometyl) - 3 - cefem...

机译:仍用于7(α-氨基-对羟基苯乙酰胺基)-3-(1-甲基-5-四唑甲基)-3-头孢甲酸和7(α-氨基-对羟基苯乙酰胺基)-3-(5-甲基- 1,3,4-噻二唑-2-ylmeometyl)-3-头孢氨苄...

摘要

1363833 3-Triazolylthiomethyl cephalsporins SMITHKLINE CORP 21 Feb 1973 [14 June 1972 15 Sept 1972] 8511/73 Headings C2A and C2C Novel cephalosporins having the Formula (I) wherein R is 1,2,3-triazolyl which may be substituted with 1 or 2 groups selected from C 1 -C 4 alkyl and trifluoromethyl are prepared by (a) N-acylating an appropriate 7-amino-3- (1,2,3 - triazolylthiomethyl) - cephem - carboxylic acid with an amino-protected phydroxyphenylglycine or N-acylating derivative thereof; or (b) reacting. 7--amino-p-hydroxyphenylacetamidocephalosporanic acid having the -amino group protected, with an appropriate mercaptomethyl-1,2,3-triazole. Alternatively 7-aminocephalosporanic acid may be reacted according to both of (a) and (b). The amino-protecting group is then removed to give the compound of formula (I). The inventive compounds (I) may be used in pharmaceutical compositions having antibiotic activity, admixed with a pharmaceutical diluent or carrier. The sodium salt of 5-mercapto-4-methyl-1,2,3- triazole is prepared by refluxing 5-benzamido-4- methyl-1,2,3-thiadiazole with aqueous NaOH, and treating an ethyl acetate extract of the product with sodium 2-ethylhexanoate to precipitate the said sodium salt.
机译:1363833 3-三唑基硫代甲基头孢菌素SMITHKLINE CORP 1973年2月21日[1972年6月14日1972年9月15日]标题C2A和C2C具有式(I)的新型头孢菌素,其中R为可被1或1取代的1,2,3-三唑基选自C 1 -C 4烷基和三氟甲基的2个基团是通过(a)用氨基保护的对羟基苯基甘氨酸将合适的7-氨基-3-(1,2,3-三唑基硫代甲基)-头孢烯-羧酸N-酰化而制备的。其N-酰化衍生物;或(b)反应。用适当的巯基甲基-1,2,3-三唑保护-氨基的7-氨基-对-羟基苯基乙酰氨基头孢烷酸。或者,可以根据(a)和(b)两者使7-氨基头孢烷酸反应。然后除去氨基保护基,得到式(I)的化合物。本发明化合物(I)可用于具有抗生素活性的药物组合物中,并与药物稀释剂或载体混合。 5-巯基-4-甲基-1,2,3-三唑的钠盐是通过将5-苯甲酰胺基-4-甲基-1,2,3-噻二唑与NaOH水溶液回流并处理乙酸乙酯的乙酸乙酯提取物制得的。将产物与2-乙基己酸钠一起沉淀出所述钠盐。

著录项

  • 公开/公告号SE404190B

    专利类型

  • 公开/公告日1978-09-25

    原文格式PDF

  • 申请/专利权人 * SMITH KLINE & FRENCH LABORATORIES;

    申请/专利号SE19730004545

  • 发明设计人 G L * DUNN;J R E * HOOVER;

    申请日1973-03-30

  • 分类号C07D501/36;

  • 国家 SE

  • 入库时间 2022-08-22 22:38:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号